Want to create an interactive transcript for this episode?
Podcast: Viewsroom
Episode: Novo Nordisk is Denmark’s big little problem
Description: As war rages and Donald Trump looms, a recent election featured little mention of the ailing $164 bln drugmaker, once so successful it distorted economic figures. In this week’s Viewsroom, Breakingviews columnists discuss the future of weight loss pills, and Novo’s place in it.
(This episode has been corrected to remove a statement that Novo Nordisk’s Wegovy pill needs to be refrigerated.)
Novo Nordisk's illness offers painful lessons
Novo Nordisk’s falling knife is still gathering speed
Obesity pills are shaky Hail Mary for Novo Nordisk
Visit the Thom...